Immunomodulation of contact dermatitis.
Lauerma
A I
AI
Department of Dermatology, Helsinki University Central Hospital, Finland.
D000818:Animals; D003877:Dermatitis, Contact / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D004137:Dinitrochlorobenzene / Q000009:adverse effects / Q000276:immunology; D004195:Disease Models, Animal; D006168:Guinea Pigs; D006801:Humans; D007118:Immunoassay; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008198:Lymph Nodes / Q000187:drug effects / Q000276:immunology; D008297:Male; D010081:Oxazolone / Q000276:immunology / Q000633:toxicity; D016559:Tacrolimus / Q000627:therapeutic use*
D004137:Dinitrochlorobenzene; D007166:Immunosuppressive Agents; D010081:Oxazolone; D016559:Tacrolimus